Concepedia

Author

Arminder Deol

London School of Hygiene & Tropical MedicineORCID

Also Known As

A Deol, A. Deol, A. K. Deol, Adam J. Kucharski, Alicia Rosello, Amrit K. Deol, Arjan Deol, Arminder Deol, Arminder K Deol, Arminder K. Deol

60

Publications

5.5K

Citations

23

H-Index

12

Concepts

All Affiliations

London School of Hygiene & Tropical MedicineImperial College LondonUniversity of CambridgeUniversity College LondonUniversity of Cape Town
AD

About

Arminder Deol is an author at London School of Hygiene & Tropical Medicine specializing in covid-19, epidemiology, and contact tracing.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

1.2K

2

Public Health

1

1

1.2K

3

Epidemiology

1

1

1.2K

4

Global Health

1

1

1.2K

5

Population Health Sciences

1

1

1.2K

Arminder Deol

×

18

Publications

4.2K

Citations

15

H-Index

YearCitations

Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study

Andrew Clark, Mark Jit, Charlotte Warren‐Gash,

The Lancet Global Health

2020

1.2K

Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study

Nicholas G. Davies, Adam J. Kucharski, Rosalind M. Eggo,

The Lancet Public Health

2020

963

Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study

Adam J. Kucharski, Petra Klepac, Andrew J. K. Conlan,

The Lancet Infectious Diseases

2020

945

Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection

Kaja Abbas, Simon R. Procter, Kevin van Zandvoort,

The Lancet Global Health

2020

369

Schistosomiasis — Assessing Progress toward the 2020 and 2025 Global Goals

Arminder Deol, Fiona Fleming, Beatriz Calvo-Urbano,

New England Journal of Medicine

2019

228

An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoea</i> in genitourinary medicine clinics in England

Jeff Round, John Macleod, Simon Goldenberg,

Sexually Transmitted Infections

2013

74

Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era

Rosanna C. Barnard, Nicholas G. Davies, James D Munday,

Nature Communications

2022

63

Evaluating the variation in the projected benefit of community-wide mass treatment for schistosomiasis: Implications for future economic evaluations

Hugo C. Turner, James E. Truscott, Alison A. Bettis,

Parasites & Vectors

2017

55

The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study

Rebecca A. Clark, Christinah Mukandavire, Allison Portnoy,

The Lancet Global Health

2023

54

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study

Allison Portnoy, Rebecca A. Clark, Matthew Quaife,

PLoS Medicine

2023

48

Page 1